Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Maria J Tort"'
Autor:
Mark H. Rozenbaum, Erica Chilson, Raymond Farkouh, Liping Huang, Alejandro Cane, Adriano Arguedas, Maria J. Tort, Vincenza Snow, Ahuva Averin, Derek Weycker, Dhwani Hariharan, Mark Atwood
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 4, Pp 745-760 (2024)
Abstract Introduction A 20-valent pneumococcal conjugate vaccine (PCV20) was recently recommended for use among US children. We evaluated the cost-effectiveness of PCV20 among children aged 6 years with chronic medical conditions (CMC+) and children
Externí odkaz:
https://doaj.org/article/b712d8278380477ba2012c98d05adfdf
Publikováno v:
Vaccines, Vol 12, Iss 11, p 1279 (2024)
(1) Background/Objectives: Two pneumococcal conjugate vaccines, 15-(PCV15) and 20-(PCV20) valent formulations, are routinely recommended for US children in a 3+1 schedule. The first three doses are administered during the first year of life at 2, 4,
Externí odkaz:
https://doaj.org/article/80a73adcd0ab4c55b00f1901c00ebb59
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)
Invasive meningococcal disease (IMD) is rare but associated with high morbidity and mortality. In the United States, the most vulnerable age groups are infants and adolescents/young adults, and the most common type of IMD is caused by serogroup B (Me
Externí odkaz:
https://doaj.org/article/7f73830082f94230b31fa9d585f6087f
Autor:
Tamera Coyne-Beasley, Joseph Bocchini, Alejandro Cane, Cindy Burman, Maria J Tort, Jessica Presa
Publikováno v:
Open Forum Infectious Diseases
Background US adolescents and young adults are at particular risk of invasive meningococcal disease (IMD). In 2018, menincococcal serogroup B was responsible for 36% of IMD cases in the US overall and for 66% of cases in adolescents and young adults.
Publikováno v:
Open Forum Infectious Diseases. 3
Publikováno v:
Allergy and Asthma Proceedings. 32:151-158
Olopatadine hydrochloride nasal spray 0.6% (OLO) and azelastine nasal spray 137 micrograms (AZE) are effective in treating allergic rhinitis and AZE is indicated for nonallergic vasomotor rhinitis (VMR). This study evaluates the relative safety and e
Autor:
Douglas Swanson, Maria J. Tort, Christopher J. Harrison, Angee McDaniel, Fernando Merino, Rebecca Horvat, Erin Atwood, R. Scott Duncan
Publikováno v:
Open Forum Infectious Diseases. 2
Autor:
Anne James, Douglas Swanson, Richard V. Goering, Christopher J. Harrison, Angee McDaniel, Maria J. Tort, Fernando Merino, Erin Atwood, Rebecca Horvat
Publikováno v:
Open Forum Infectious Diseases. 2
Autor:
Michael S. Blaiss, Maria J. Tort
Publikováno v:
The World Allergy Organization Journal
Purpose To further assess the prevention of ocular itching with olopatadine hydrochloride ophthalmic solution, 0.2% (OLO) in patients with allergic conjunctivitis. Methods This was a post-hoc analysis of 85 patients participating in 2 prospective, ra
Publikováno v:
Optometry - Journal of the American Optometric Association. 81:285-286